These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23783007)

  • 21. Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study.
    Di Rezze S; Frasca V; Inghilleri M; Durastanti V; Cortese A; Giacomelli E; Millefiorini E
    Clin Neuropharmacol; 2012; 35(5):231-4. PubMed ID: 22751087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.
    Karp JF; Whyte EM; Lenze EJ; Dew MA; Begley A; Miller MD; Reynolds CF
    J Clin Psychiatry; 2008 Mar; 69(3):457-63. PubMed ID: 18251622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.
    Hunziker ME; Suehs BT; Bettinger TL; Crismon ML
    Clin Ther; 2005 Aug; 27(8):1126-43. PubMed ID: 16199241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
    Berk M; du Plessis AD; Birkett M; Richardt D
    Int Clin Psychopharmacol; 1997 May; 12(3):137-40. PubMed ID: 9248869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.
    Härmark L; van Puijenbroek E; van Grootheest K
    Eur J Clin Pharmacol; 2013 Feb; 69(2):209-15. PubMed ID: 22688722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial.
    Mico' U; Bruno A; Pandolfo G; Maria Romeo V; Mallamace D; D'Arrigo C; Spina E; Zoccali RA; Muscatello MR
    Int Clin Psychopharmacol; 2011 Nov; 26(6):303-10. PubMed ID: 21934625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
    Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
    Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
    Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.
    Pitchot W; Scantamburlo G; Ansseau M
    Psychiatr Danub; 2010 Nov; 22 Suppl 1():S106-7. PubMed ID: 21057413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.
    van Ophoven A; Hertle L
    J Urol; 2007 Feb; 177(2):552-5. PubMed ID: 17222632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
    Stovall R; Brahm NC; Crosby KM
    Consult Pharm; 2009 Oct; 24(10):765-8. PubMed ID: 20017411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.
    Maund E; Tendal B; Hróbjartsson A; Jørgensen KJ; Lundh A; Schroll J; Gøtzsche PC
    BMJ; 2014 Jun; 348():g3510. PubMed ID: 24899650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.